Catcher Technology Co., Ltd. expects a mild recovery in its laptop casing business this year. Coupled with continued depreciation and income from non-core financial investments, the company is poised to maintain a stable profit foundation. Regarding its transformation strategy, Catcher Tech continues to develop in the medical and semiconductor-related fields. Insights into this transformation can be gleaned from the shareholdings of Catcher Tech' investment companies in recent years. 

Catcher Tech's investment portfolio includes Ke-yao (transliteration), Intech Biopharm Ltd., Maunsell technology Co. Ltd., and Catcher Medtech Co., Ltd. According to year-end financial data from last year, Catcher Tech holds over 10% stakes in listed medical device companies including United Orthopedic Co., Bioteque Co., and INTAI Technology Corp. It holds nearly 10% of Apex Biotechnology Corp., and nearly 7% of Wiseconn. 

In the semiconductor equipment-related components and materials sector, the company has invested in Highlight Tech Corp., Feedback Tech Corp., Calitech Co. Ltd., Shih Her Technologies Inc, and Yeedex Electronic Corp. 

Catcher Tech focuses on the medical and semiconductor fields primarily due to their high profitability and growth prospects. During last year's investor conference, Chairman Shui-Shu Hung expressed optimism about numerous well-managed companies in Taiwan. However, due to their smaller scale and difficulty in cross-industry operations, Catcher Tech plans to first make financial investments in specific areas. They hope for close collaboration in the future and expect organic growth to integrate better with existing external supply chains, collectively pursuing international orders. 

Resource (Mandarin): 可成布局醫療、半導體，轉投資持股透端倪